Showing 1,321 - 1,340 results of 1,890 for search '"Type 2 diabetes"', query time: 0.10s Refine Results
  1. 1321

    In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents by Diana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes, Feliciano Tamay-Cach, Jessica Elena Mendieta-Wejebe

    Published 2021-01-01
    “…Thiazolidinediones (TZDs), used to treat type 2 diabetes mellitus, act as full agonists of the peroxisome proliferator-activated receptor gamma. …”
    Get full text
    Article
  2. 1322

    Charge-Based Inhibitors of Amylin Fibrillization and Toxicity by Sharadrao M. Patil, Andrei T. Alexandrescu

    Published 2015-01-01
    “…To test the hypothesis that electrostatic repulsion is an important force opposing amyloid fibril assembly, we designed peptides that substitute strings of positively or negatively charged residues into the sequence of the amyloidogenic hormone amylin, which contributes to type 2 diabetes pathology. Arg-1 and Arg-2 substitute four positively charged arginines for segments that in structural models of amylin fibrils form the end of strand β1 and the beginning of strand β2, respectively. …”
    Get full text
    Article
  3. 1323

    Genetic, Functional, and Immunological Study of ZnT8 in Diabetes by Qiong Huang, Jie Du, Chengfeng Merriman, Zhicheng Gong

    Published 2019-01-01
    “…A common ZnT8 gene (SLC30A8) polymorphism increases the risk of type 2 diabetes mellitus (T2DM), and rare mutations may present protective effects. …”
    Get full text
    Article
  4. 1324

    Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems by Salwa O. Mekki, Amal A. Hassan, Afnan Falemban, Nashwa Alkotani, Salem M. Alsharif, Ahmed Haron, Basim Felemban, Mohammad S. Iqbal, Aisha Tabassum

    Published 2020-01-01
    “…Here, we present a case of a 52-year-old male who has type 2 diabetes mellitus and a past history of treated pulmonary tuberculosis. …”
    Get full text
    Article
  5. 1325

    Attitudes Regarding Participation in a Diabetes Screening Test among an Assyrian Immigrant Population in Sweden by Susanne Andersson, Veronika Karlsson, Louise Bennet, Klas Fellbrant, Margareta Hellgren

    Published 2016-01-01
    “…Immigrants from the Middle East have higher prevalence and incidence of type 2 diabetes (T2D) compared with native Swedes. The aim of the study was to describe and understand health beliefs in relation to T2D as well as attitudes regarding participation in a screening process in a local group of Assyrian immigrants living in Sweden. …”
    Get full text
    Article
  6. 1326

    Effect of Social Factors and the Natural Environment on the Etiology and Pathogenesis of Diabetes Mellitus by Guangtong Dong, Lianlian Qu, Xuefeng Gong, Bing Pang, Weitian Yan, Junping Wei

    Published 2019-01-01
    “…Type 2 diabetes mellitus (T2DM) is currently a public health problem worldwide and a threat to human health and social development. …”
    Get full text
    Article
  7. 1327

    Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus by Yang Xin Zi Xu, Shengyan Xi, Xiaoyan Qian

    Published 2019-01-01
    “…We further reviewed them and their relatives in relation to type 2 diabetes mellitus and found more evidence of metabolic benefits. …”
    Get full text
    Article
  8. 1328

    On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides by Marianna Flora Tomasello, Alessandro Sinopoli, Giuseppe Pappalardo

    Published 2015-01-01
    “…Pancreatic islets in type 2 diabetes mellitus (T2DM) patients are characterized by reduced β-cells mass and diffuse extracellular amyloidosis. …”
    Get full text
    Article
  9. 1329

    Exploring mechanisms of insulin action and strategies to treat diabetes by Takayoshi Sasako

    Published 2024-07-01
    “…Moreover, we reported the effects of intensive multifactorial intervention on diabetic vascular complications and mortality in patients with type 2 diabetes in a large-scale clinical trial, the J-DOIT3, and the results of subsequent sub-analyses of renal events and fracture events. …”
    Get full text
    Article
  10. 1330

    Management of a Difficult-to-Treat Diabetic Foot Wound Complicated by Osteomyelitis: A Case Study by Maram Alkhatieb, Hatan Mortada, Hattan Aljaaly

    Published 2020-01-01
    “…We report a case of a 51-year-old male patient, with a known history of type 2 diabetes mellitus who presented to our hospital with a history of two ulcers, one that he was mainly complaining of, which was actively infected and located at the posterior part of the distal left leg, and the second, dry ulcer caused by unrecognized trauma, located on the heel of the same limb. …”
    Get full text
    Article
  11. 1331

    Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting Oxidative Stress by Dong-xing Liu, Chen-sheng Zhao, Xiao-na Wei, Yi-peng Ma, Jian-kun Wu

    Published 2022-01-01
    “…Studies have demonstrated that improving insulin resistance in type 2 diabetes mellitus (T2DM) can benefit patients with PD. …”
    Get full text
    Article
  12. 1332

    Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats by Mohamed I. Saad, Maher A. Kamel, Mervat Y. Hanafi

    Published 2015-01-01
    “…Type 2 diabetes mellitus (T2DM) is a group of metabolic disorders characterized by hyperglycemia owing to insulin resistance and/or insulin deficiency. …”
    Get full text
    Article
  13. 1333

    Cholecystoduodenal Stenting: An Option in Complicated Acute Calculous Cholecystitis in the Elderly Comorbid Patient by Brady Bonner, Nicholas I. Brown, Varghese Pynadath Joseph, Manju Dashini Chandrasegaram

    Published 2018-01-01
    “…She was unable to have a cholecystectomy due to multiple comorbidities including morbid obesity, type 2 diabetes, Guillain–Barrè syndrome, chronic sacral pressure ulcer, and severe cardiac disease. …”
    Get full text
    Article
  14. 1334

    Nutritional and Phytochemical Composition and Associated Health Benefits of Oat (Avena sativa) Grains and Oat-Based Fermented Food Products by Getaneh Firew Alemayehu, Sirawdink Fikreyesus Forsido, Yetenayet B. Tola, Endale Amare

    Published 2023-01-01
    “…Oats are a good source of soluble dietary fiber, particularly β-glucan, which has outstanding functional properties and is extremely important in human nutrition. β-Glucan has been shown to lower blood cholesterol and glucose absorption in the intestine, thereby preventing diseases such as cardiovascular injury, dyslipidemia, hypertension, inflammatory state, and type 2 diabetes. Oats also contain high concentration of antioxidant compounds. …”
    Get full text
    Article
  15. 1335

    PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways by Yves Lecarpentier, Victor Claes, Jean-Louis Hébert

    Published 2010-01-01
    “…Dysfunction of clock genes and PPARγ may lead to hyperphagia, obesity, metabolic syndrome, myocardial infarction and sudden cardiac death, In pathological conditions, regulatory processes of the cardiovascular system may bifurcate towards new states, such as those encountered in hypertension, type 2 diabetes, and heart failure. Numerous of these oscillatory mechanisms, organized in time and space, behave far from equilibrium and are “dissipative structures”.…”
    Get full text
    Article
  16. 1336

    Crescentic Glomerulonephritis and Membranous Nephropathy: A Rare Overlap by Mohamedanwar Ghandour, Heba Osman, Samer Alkassis, Alix Charles, Kristina Zalewski, Jarrett Weinberger, Yahya Malik-Osman, Zeenat Y. Bhat

    Published 2022-01-01
    “…Our patient is a 53-year-old Hispanic male with a medical history of tobacco use, type 2 diabetes mellitus, and hypertension who presented with hematuria and was found to have nephrotic range proteinuria and renal impairment. …”
    Get full text
    Article
  17. 1337

    Appendicitis After Initiation of Tirzepatide by Chan G, Ansar M, Klein M

    Published 2025-01-01
    “…Garrett Chan1, Mariam Ansar1, Marlena Klein1,21Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA; 2Cooper Medical School of Rowan University, Camden, New Jersey, USACorrespondence: Garrett Chan, Email chan-garrett@cooperhealth.eduAbstract: Tirzepatide is a GLP1/GIP receptor agonist that is used to treat type 2 diabetes and promote weight loss. Common side effects of Tirzepatide include nausea, vomiting, and diarrhea. …”
    Get full text
    Article
  18. 1338

    Role of Mitochondria-Associated Endoplasmic Reticulum Membrane in Inflammation-Mediated Metabolic Diseases by Themis Thoudam, Jae-Han Jeon, Chae-Myeong Ha, In-Kyu Lee

    Published 2016-01-01
    “…Inflammation is considered to be one of the most critical factors involved in the development of complex metabolic diseases such as type 2 diabetes, cancer, and cardiovascular disease. A few decades ago, the discovery of mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) was followed by the identification of its roles in regulating cellular homeostatic processes, ranging from cellular bioenergetics to apoptosis. …”
    Get full text
    Article
  19. 1339

    Diabetic Muscle Infarction: A Rare Complication of Long-Standing and Poorly Controlled Diabetes Mellitus by Shridhar N. Iyer, Almond J. Drake, R. Lee West, Robert J. Tanenberg

    Published 2011-01-01
    “…We describe a case of a 45-year-old male with an approximately 8-year history of poorly controlled type 2 diabetes mellitus with multiple microvascular complications who presented with the sudden onset of left thigh pain and swelling. …”
    Get full text
    Article
  20. 1340

    The Effect of Sleep Disruption on Cardiometabolic Health by SeokHyun Hong, Da-Been Lee, Dae-Wui Yoon, Seung-Lim Yoo, Jinkwan Kim

    Published 2025-01-01
    “…Epidemiological studies have consistently demonstrated that insufficient sleep duration (<7 h) and poor sleep quality are associated with increased risks of obesity, type 2 diabetes, and cardiovascular disease. The underlying mechanisms are multifaceted, involving the disruption of circadian clock genes, alterations in glucose and lipid metabolism, the activation of inflammatory pathways, and the modulation of the gut microbiome. …”
    Get full text
    Article